RPG Life Sciences Limited — Updates, 29-07-2026: General Updates
29-07-2026 | 11:36 pm
29-07-2026 | 11:36 pm
RPG Life Sciences sells its API business to its WOS, RPG Active Pharma, for ~Rs. 33.55 Cr. RPG Active Pharma will receive Rs. 243.33 Cr from investors for a ~40% stake and acquire Actis Generics for Rs. 80 Cr to boost API growth.
No comments yet. Be the first to comment!
